Worse Breast Cancer Prognosis of BRCA1/BRCA2 Mutation Carriers: What's the Evidence? A Systematic Review With Meta-Analysis

PLoS ONE - United States
doi 10.1371/journal.pone.0120189
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Screening BRCA1 and BRCA2 Mutation Carriers for Breast Cancer

Cancers
Cancer ResearchOncology
2018English

Plasma Osteoprotegerin and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

Oncotarget
Oncology
2016English

Uterine Cancer in Jewish Israeli BRCA1/BRCA2 Mutation Carriers

Cancer
Cancer ResearchOncology
2018English

Polymorphic Repeat Length in the AIB1 Gene and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: A Meta-Analysis of Observational Studies

PLoS ONE
Multidisciplinary
2013English

Phenotypic Analysis of Familial Breast Cancer: Comparison of BRCAx Tumors With BRCA1-, BRCA2-carriers and Non-Familial Breast Cancer

European Journal of Surgical Oncology
MedicineOncologySurgery
2015English

Methionine-Dependence Phenotype in the De Novo Pathway in BRCA1 and BRCA2 Mutation Carriers With and Without Breast Cancer

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2008English

A Prior Diagnosis of Breast Cancer Is a Risk Factor for Breast Cancer in BRCA1 and BRCA2 Carriers

Current Oncology
Oncology
2014English

Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality

JAMA - Journal of the American Medical Association
Medicine
2010English

Annual Screening Strategies in BRCA1 and BRCA2 Gene Mutation Carriers: A Comparative Effectiveness Analysis

Breast Diseases
OncologySurgery
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy